Saturday 17 October 2026
Export ACB’s income statement to Excel — free account
Aurora Cannabis Inc.
ACB Healthcare Drug Manufacturers Specialty & Generic
Aurora Cannabis Inc.’s revenue for fiscal 2026 (year ended March 2026) was $232.0 million, down 5.95% from fiscal 2025. In the quarter to June 2026, revenue fell 31.2%, EPS grew 75.0%, free cash flow fell 293.6% and total debt fell 82.5%, each against the same quarter a year earlier.
3.99
0.11
−2.68%
Follow ACB
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 3 | 4 | 4 |
| (10.17%) | (15.13%) | (21.82%) | (19.85%) | ||
| (7.47%) | (10.88%) | (16.82%) | (15.19%) | ||
ROIC |
(3.88%) | (8.26%) | (7.98%) | (5.58%) | |
Return on Tangible Assets |
(10.46%) | (15.94%) | (26.81%) | (23.74%) | |
Average Days of Receivables |
47.12 | 43.27 | 50.75 | 51.59 | |
Free Cash Flow per Share |
(0.21) | (0.37) | (0.45) | (0.59) | |
Free Cash Flow |
(12.09) | (21.26) | (25.30) | (36.10) | |
Capital Expenditures |
(13.72) | (14.44) | (15.52) | (15.79) | |
| Other line items | |||||
Cash ROIC |
(2.07%) | (3.63%) | (5.03%) | (7.21%) | |
Accounts Receivable Turnover |
8.29 | 7.97 | 7.39 | 7.24 | |
Accounts Payable Turnover |
4.59 | 3.55 | 2.97 | 2.11 | |
Inventory Turnover |
0.93 | 1.01 | 0.89 | 0.70 | |
Average Days of Payables |
88.49 | 101.61 | 100.39 | 141.96 | |
Days of Inventory on Hand |
398.07 | 344.37 | 347.40 | 468.48 | |
Tax Rate |
0.16 | 0.09 | 0.04 | 0.06 | |
Research and Development Expense of Revenue |
0.94% | 1.02% | 1.25% | 1.97% | |
Selling, General and Administrative Expense of Revenue |
48.68% | 48.40% | 54.12% | 58.29% | |
Share Based Compensation of Revenue |
3.04% | 2.43% | 2.27% | 2.00% | |
Interest Coverage |
(3.84) | (7.73) | (25.80) | (70.51) | |
Operating CF/Net income |
(0.04) | 0.11 | 0.11 | 0.25 | |
Depreciation/Fixed assets |
0.10 | 0.11 | 0.15 | 0.11 | |
Capex/Depreciation |
(0.69) | (0.70) | (1.19) | (1.38) | |
Revenue per Share |
4.65 | 4.71 | 4.09 | 3.40 | |
Operating CF per Share |
0.03 | (0.12) | (0.17) | (0.33) | |
Capex per Share |
(0.24) | (0.25) | (0.27) | (0.26) | |
Capex to Sales |
0.05 | 0.05 | 0.07 | 0.08 |
Columns are period end dates